Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population-Reference-Cited by-同舟云学术

Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population

Published:2006-10 Issue:1-2 Volume:601 Page:171-178
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Hirai Yuko,Kodama Yoshiaki,Moriwaki Shin-Ichi,Noda Asao,Cullings Harry M.,MacPhee Donald G.,Kodama Kazunori,Mabuchi Kiyohiko,Kraemer Kenneth H.,Land Charles E.,Nakamura Nori

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference26 articles.

1. Defective repair replication of DNA in xeroderma pigmentosum;Cleaver;Nature,1968

2. DNA repair protects against cutaneous and internal neoplasia evidence from xeroderma pigmentosum;Kraemer;Carcinogenesis,1984

3. Cancer in xeroderma pigmentosum and related disorders of DNA repair;Cleaver;Nat. Rev. Cancer,2005

4. Genetics and skin cancer of xeroderma pigmentosum in Japan;Takebe;Jpn. J. Cancer Res.,1987

5. Xeroderma pigmentosum—bridging a gap between clinic and laboratory;Moriwaki;Photodermatol. Photoimmunol. Photomed.,2001

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas;Experimental Eye Research;2024-06

2. DNA repair-related heritable photosensitivity syndromes: Mutation landscape in a multiethnic cohort of 17 multigenerational families with high degree of consanguinity;DNA Repair;2024-04

3. DNA Repair Disorders with Cutaneous Features;Rook's Textbook of Dermatology;2024-02-20

4. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression;Brain;2023-12-01

5. Deep intronic founder mutations identified in the ERCC4 / XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum;Proceedings of the National Academy of Sciences;2023-06-26